Target intelligence / Profile preview

Immunoglobulin heavy joining 3 pseudogene (IGHJ3P)

Target
IGHJ3P
Molecular classification
Other (Immunoglobulin pseudogene)
01

Overview

**Immunoglobulin heavy joining 3 pseudogene (IGHJ3P)** is a non-functional, pseudogene member of the immunoglobulin heavy joining (IGHJ) gene segment family found in the immunoglobulin heavy-chain locus. Unlike functional IGHJ genes that are critical components for antibody gene rearrangement during B cell development, pseudogenes such as IGHJ3P do not encode active gene products and are not involved in immunological signaling, antigen recognition, or V(D)J recombination. The presence of “P” in the gene symbol and designation as a pseudogene means it is not expressed as a functional protein and does not serve as a therapeutic target[2]. **Key points:** - IGHJ3P is a **pseudogene** and not a functional receptor, enzyme, transporter, or transcription factor. - It does not play a direct biological or disease role. - It is not a drug target and has no mechanism of action, drug interactions, biomarker applications, or specific safety concerns associated with it. - Its listing under possible target names is likely mistaken because it is not a gene product with biological activity or therapeutic interest[2].

Other names
Jpsi3IGHJ3P

Beyond the preview

Go deeper on Immunoglobulin heavy joining 3 pseudogene (IGHJ3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy joining 3 pseudogene (IGHJ3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call